- HMS Community Values
- Introduction to Clinical Research Training
- Medical Education
- United Kingdom Clinical Scholars Research Training
- Vanderbilt Hall
- What it Means to Be a Harvard Doctor
- Diversity Commitment
- Tuition, Fees, & Expenses
- Interview Day
- The Neighborhood
- Admissions FAQs
- Contact Admissions
- Financial Aid
- Office of the Registrar
- Campus Planning and Facilities
- Ombuds Office
- Committee on Microbiological Safety
- Human Resources
- The Academy
- Office for Academic and Clinical Affairs
- Joint Committee on the Status of Women
- Global Health Research Core
- Global Clinical Scholars Research Training Program
- HMA Standing Committee on Animals
- Office of Research Compliance
- Harvard Medical School Event Calendar
- Office of Diversity RIA Program
- The Dean's Perspective
- Department of Pathology
- Harvard Mahoney Neuroscience Institute
- OHRA Home
- Office of Research Subject Protection
- Tools and Technology
- Alumni Association
- Cancer Biology & Therapeutics Program
- Celiac Program
- Department of Medicine
- HMS Information Technology
- HMS TransMed Program
- Introduction to the Practice of American Medicine
- Office of Communications & External Relations
- Big Data In Healthcare
- Institutional Planning and Policy
- Master of Medical Sciences In Clinical Investigation
- Office of Global Education
- Portugal Clinical Scholars Research Training Program
- Safety Quality Informatics and Leadership
- South American Clinical Research Training Program | SACRT
- Shenzhen-HMS Initiative in International Education
- test page
- HMS Foundation Funds
- Contact @HMS
- Office of Global Education
- Human Resources
- Jobs @ HMS
- Dental Medicine
- Harvard University
- Contact us
Stem Cell Memory
They say we can't escape our past—no matter how much we change, we still have the memory of what came before. The same can be said of our cells.
Adult cells, such as skin or blood cells, have a cellular “memory,” or record of how the cell changes as it develops from an uncommitted embryonic cell into a specialized adult cell.
Now, Harvard Medical School researchers at the Harvard Stem Cell Institute and at Massachusetts General Hospital, in collaboration with scientists from the Institute of Molecular Biotechnology (IMBA) and the Research Institute of Molecular Pathology (IMP) in Vienna, have identified genes that, when suppressed effectively, erase a cell's memory.
This makes the cell more susceptible to reprogramming and, consequently, makes the process of reprogramming quicker and more efficient.
“We began this work because we wanted to know why a skin cell is a skin cell, and why does it not change its identity the next day, or the next month, or a year later?”—Konrad Hochedlinger
The study was recently published in Nature.
“We began this work because we wanted to know why a skin cell is a skin cell, and why does it not change its identity the next day, or the next month, or a year later?” said co-senior author Konrad Hochedlinger, professor of stem cell and regenerative biology at HMS, HMS professor of medicine at Massachusetts General Hospital and a principal faculty member at the Harvard Stem Cell Institute.
Every cell in the human body has the same genome, or DNA blueprint, and it is how those genes are turned on and off during development that determines what kind of adult cell each will become. By manipulating those genes and introducing new factors, scientists can unlock dormant parts of an adult cell's genome and reprogram it into another cell type.
However, “a skin cell knows it is a skin cell,” said IMBA's Josef Penninger, even after scientists reprogram those skin cells into induced pluripotent stem cells (iPS cells), a process that would ideally require a cell to “forget” its identity before assuming a new one. Cellular memory is often conserved, acting as a roadblock to reprogramming.
“We wanted to find out which factors stabilize this memory and what mechanism prevents iPS cells from forming,” Penninger said.
To identify potential factors, the team established a genetic library targeting known chromatin regulators—genes that control the packaging and bookmarking of DNA and are involved in creating cellular memory.
Hochedlinger and Sihem Cheloufi, co-first author and a research fellow in genetics in Hochedlinger's lab, designed a screening approach that tested each of those factors.
Of the 615 factors screened, the researchers identified four chromatin regulators, three of which had not yet been described, as potential roadblocks to reprogramming. In comparison to the three- to four-fold increase seen by suppressing previously known roadblock factors, inhibiting the newly described CAF1 (chromatin assembly factor 1) made the process 50- to 200-fold more efficient. Moreover, in the absence of CAF1, reprogramming turned out to be much faster: While the process normally takes nine days, the researchers could detect the first iPS cell after four days.
“The CAF1 complex ensures that during DNA replication and cell division, the daughter cells keep their memory, which is encoded on the histones that the DNA is wrapped around," said Ulrich Elling, a co-first author from IMBA. "When we block CAF-1, daughter cells fail to wrap their DNA the same way, lose this information and convert into blank sheets of paper. In this state, they respond more sensitively to signals from the outside, meaning we can manipulate them much more easily.”
By suppressing CAF-1, the researchers were also able to facilitate the conversion of one type of adult cell directly into another, skipping the intermediary step of forming iPS cells, via a process called direct reprogramming, or transdifferentiation. Thus, CAF-1 appears to act as a general guardian of cell identity whose depletion facilitates both the interconversion of one adult cell type to another as well as the conversion of specialized cells into iPS cells.
In finding CAF-1, the researchers identified a complex that allows cell memory to be erased and rewritten. “The cells forget who they are, making it easier to trick them into becoming another type of cell,” said Cheloufi.
CAF-1 may provide a general key to facilitate the reprogramming of cells to model disease and test therapeutic agents, IMP's Johannes Zuber explained.
“The best-case scenario,” he said, “is that with this insight, we hold a universal key in our hands that will allow us to model cells at will.”
Adapted from a Harvard Stem Cell Institute news release.
Stay informed via email on the latest news, research, and
media from Harvard Medical School.